EWS
GILD icon

Evergreen Wealth Solutions’s Gilead Sciences GILD Stock Holding History

Evergreen Wealth Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Sell
1,791
-294
-14% -$41.2K 0.02% 361
2025
Q4 		$256K Sell
2,085
-33
-2% -$4.01K 0.04% 183
2025
Q3 		$235K Sell
2,118
-15
-0.7% -$1.71K 0.13% 106
2025
Q2 		$236K Buy
2,133
+44
+2% +$4.68K 0.14% 103
2025
Q1 		$234K Buy
+2,089
New +$216K 0.16% 97
2024
Q1 		– Sell
-2,558
Closed -$207K – 123
2023
Q4 		$207K Buy
+2,558
New +$199K 0.18% 106

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Evergreen Wealth Solutions's GILD Position: Q1 2026 in Review

Evergreen Wealth Solutions reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $41.2K and leaving 1,791 shares worth $250K. The position accounts for 0.02% of the portfolio, ranked #361.

Evergreen Wealth Solutions first reported a position in GILD in Q4 2023 and has held it in 6 quarters since. The position peaked at $256K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Evergreen Wealth Solutions held 1,791 shares of Gilead Sciences worth $250K as of Q1 2026.
  • Evergreen Wealth Solutions sold 294 Gilead Sciences shares in Q1 2026, an estimated $41.2K.
  • Gilead Sciences made up 0.02% of Evergreen Wealth Solutions's portfolio in Q1 2026, its #361 holding.
  • Evergreen Wealth Solutions first reported a position in Gilead Sciences in Q4 2023 and has held it in 6 quarters since.
  • Evergreen Wealth Solutions's Gilead Sciences position peaked at $256K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Evergreen Wealth Solutions's 13F filing for Q1 2026, filed 15 May 2026.